Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage

Study Overview
=================
Brief Summary
-----------------
In the aetiology of postpartum uterine atony, hypoxia is considered an important factor although some suggest that peripheral oxygen saturation is not influenced by oxygen inhalation in women during the first and second stages of labor. Enhancing oxygen delivery to myometrium through additional inhaled oxygen may improve uterine contractions. Therefore, it is reasonable to consider that oxygen inhalation may promote myometrial contraction and prevent postpartum haemorrhage (PPH) due to uterine atony. The tendency for the uterus to relax in women encountering respiratory problems immediately after cesarean section under general anaesthesia further strengthened this theory. The aim of this study was to evaluate the effectiveness of oxygen inhalation immediately after vaginal delivery on blood loss. The investigators hypothesized that inhaled oxygen helps to maintain uterine retraction during immediate postpartum period and hence reduces vaginal blood loss.

Official Title
-----------------
Phase 3 Study of Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage

Conditions
-----------------
Postpartum Hemorrhage

Intervention / Treatment
-----------------
* Drug: oxygen


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: gestational age between 37 and 42 weeks; singleton pregnancy; live fetus; cephalic presentation; neonatal birth weight of 2500-4500 g; parity between one and five; maternal age < 35 years old; vaginal birth Exclusion Criteria: blood pressure ≥ 140/90mmHg; placenta previa; placental abruption; a history of any bleeding during pregnancy; a history of curettage; cesarean section or any uterine scar; a history of postpartum hemorrhage; polyhydramnios; signs or symptoms of maternal infection; known uterine anomalies; history of any drug use during labor; abnormal placentation; coagulation defects; instrumental deliveries; hemoglobin concentration < 8 g/dL; history of anticoagulant drugs; beta-mimetic medications during pregnancy; prolongation of the first stage of labor > 15 hours

Ages Eligible for Study
-----------------
Minimum Age: 20 Years
Maximum Age: 40 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: oxygen<br> | Drug: oxygen<br>* either 8 L/minute O2 via face mask for 2 hours<br>* Other names: Women were randomized to receive either 8 L/minute O2 via face mask for 2 hours or breathed room air at the end of second stage of labor.;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The primary outcome was the amount of blood loss in the third and fourth stages of labor. | The volume of blood loss was measured by weighing a sheet soaked from the end of the delivery to 2h after birth. Because it is important to collect the blood accurately, we used a specially designed operating sheet and an electronic scale to weigh all the material (with a 1 g deviation range). The quantity of blood (ml) = (weight of used materials - weight of materials prior to use)/1.05. Hemoglobin concentration was estimated on admission and 24 h after delivery | two hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| incidences of Postpartum Haemorrhage (PPH) (≥500 ml) | The volume of blood loss was measured by weighing a sheet soaked from the end of the delivery to 2h after birth. Because it is important to collect the blood accurately, we used a specially designed operating sheet and an electronic scale to weigh all the material (with a 1 g deviation range). The quantity of blood (ml) = (weight of used materials - weight of materials prior to use)/1.05. | two hours | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
blood loss, oxygen inhalation